Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Immunocompromised people ages 12 and older are also eligible for an additional shot.
Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.
The latest Campbell Foundation research grant will help a UCLA scientist study HIV’s ability to mutate during CAR-T gene therapy.
A new clinical trial at several U.S. cancer centers will enroll people living with HIV and advanced leukemia. Here’s how to get more info.
The woman’s leukemia is in remission and she remains free of detectable HIV more than a year after stopping antiretroviral treatment.
The documentary short “Right to Try” follows Jeffrey Drew as he participates in an experimental and controversial treatment to cure HIV.
The updated report summarizes progress to date, identifies gaps and outlines recommendations for HIV cure research over the next five years.
Experts call for heightened precautions and better, more intensive therapies for COVID-19 patients with weakened immune systems.
The São Paulo Patient is no longer HIV-free after more than 15 months off treatment, but was it a relapse or reinfection?
Researchers hope to combine gene editing with a less toxic stem cell transplant. Findings may apply to cancer and other illnesses.
Researchers studied 16 people with HIV who had received a stem cell transplant for blood cancer.
“I want to be an ambassador of hope,” Adam Castillejo, 40, who grew up in Venezuela, tells The New York Times.
Trying to mimic the “Berlin Patient” cure, researchers edited the CCR5 gene in the immune stem cells of a man with leukemia and HIV.
The increasing mastery over the virus is one of humanity’s crowning achievements.
A second man’s virus went into remission following an HIV-resistant stem cell transplant to treat his cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.